Industry News
Targeting tumor-causing protein with antibody
Mar 13, 2014
Cincinnati Cancer Center (CCC) and University of Cincinnati (UC) Cancer Institute researchers have found in a phase-1 study that patients with advanced melanoma and kidney cancer who were treated with a certain antibody that targets a tumor-enhancing protein was safe, which could lead to more treatment options for patients. Read More
Bladder cancer patient with rare genetic mutations shows exceptional response to everolimus
Mar 13, 2014
A patient with advanced bladder cancer experienced a complete response for 14 months to the drug combination everolimus and pazopanib in a phase I trial, and genomic profiling of his tumor revealed two alterations that may have caused this exceptional response, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research. Read More
Quality of recovery improved by anesthetic technique for breast cancer surgery
Mar 13, 2014
Anesthesiologists using a technique similar to a dental freeze can improve the quality of recovery and decrease recovery time for breast cancer surgery patients, according to a new study.The study, from researchers at St. Michael's Hospital and Women's College Hospital, was published in the March edition of Anesthesiology. Read More
New prognostic test for breast cancer could improve patient treatment
Mar 12, 2014
A study by researchers in Nottingham has developed a new clinical test for breast cancer which aims to improve patient treatment.The Nottingham Prognostic Index Plus (NPI+) could be available to patients within two years. Read More
Worldwide standard in diagnosing melanoma pioneered by Moffitt Cancer Center
Mar 12, 2014
Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world.Sentinel nodes are the first lymph nodes to which cancer cells from a primary tumor like melanoma will spread. Read More
Promising treatment for stubborn blood cancers
Mar 12, 2014
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports* published online in Blood, the journal of the American Society of Hematology. Read More
Potent driver of metastasis identified
Mar 12, 2014
Protein Correlates with Breast, Bladder, Melanoma, and Thyroid TumorsAn international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body. Read More
After joint replacement surgery, statins may lower blood clot risk
Mar 12, 2014
Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients. Read More
Convenient, less expensive, but possibly riskier new prostate cancer treatment: SBRT
Mar 12, 2014
A faster and less expensive form of radiotherapy for treating prostate cancer may come at a price, according to a new study by Yale School of Medicine researchers - a higher rate of urinary complications.The standard external beam radiation therapy for prostate cancer is called intensity modulated radiation therapy (IMRT). Read More
Risk of prostate cancer death decreased by PSA-testing and early treatment
Mar 12, 2014
Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY, USA. Read More
Previous Page Next Page